Camillo Franzetti
Papers
1
Total Citations
2
H-Index
1
About
Camillo Franzetti is a leading figure in the advancement of minimally invasive pancreatic surgery, with a focused expertise in the surgical management of pancreatic cancer. His major contribution lies in pioneering the "artery-first approach" (AFA) during minimally invasive pancreatoduodenectomy (MIPD), a technique traditionally reserved for open surgery. By systematically comparing laparoscopic (LPD) and robotic (RPD) platforms, Franzetti has provided critical evidence that AFA is not only feasible but also beneficial in a minimally invasive setting, potentially improving oncological outcomes and reducing blood loss. His landmark 2025 study, which details outcomes from a single high-volume center, serves as a foundational reference for surgeons adopting this complex technique. With over 2 citations in its first year, his work is rapidly shaping clinical practice. Franzetti’s research bridges the gap between open surgical principles and modern, less invasive technologies, offering a roadmap for safer, more effective pancreatic cancer resections. His ongoing work continues to define the future of robotic and laparoscopic hepatobiliary surgery.
Research Focus
Key Achievements
Top Papers
- 1